PANews reported on December 30th that Neel Somani, founder of the Ethereum Layer 2 protocol Eclipse, has stepped down as executive chairman, effective October 2025PANews reported on December 30th that Neel Somani, founder of the Ethereum Layer 2 protocol Eclipse, has stepped down as executive chairman, effective October 2025

Eclipse founder Neel Somani has stepped down as executive chairman.

2025/12/30 07:43

PANews reported on December 30th that Neel Somani, founder of the Ethereum Layer 2 protocol Eclipse, has stepped down as executive chairman, effective October 2025. He stated that this move reflects his desire to fully dedicate himself to machine learning and other academic research. This departure comes at a time when Eclipse is undergoing significant product and leadership changes, including a strategic shift towards application development.

Prior to this, Somani, in collaboration with its board, spearheaded the company's strategic shift towards application development and appointed Sydney Huang as CEO. Alongside Huang's appointment, Eclipse announced it would focus on building a flagship application on its Layer 2 infrastructure. In a recent article, Huang wrote, "Eclipse's main focus must be on one application. Not several, not all of the deployed applications. This application will be announced next month."

Market Opportunity
Solayer Logo
Solayer Price(LAYER)
$0,1723
$0,1723$0,1723
-2,32%
USD
Solayer (LAYER) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.